Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand..